Literature DB >> 19007961

E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway.

Adriana Contreras-Paredes1, Erick De la Cruz-Hernández, Imelda Martínez-Ramírez, Alfonso Dueñas-González, Marcela Lizano.   

Abstract

Intra-type genome variations of high risk Human papillomavirus (HPV) have been associated with a differential threat for cervical cancer development. In this work, the effect of HPV18 E6 isolates in Akt/PKB and Mitogen-associated protein kinase (MAPKs) signaling pathways and its implication in cell proliferation were analyzed. E6 from HPV types 16 and 18 are able to bind and promote degradation of Human disc large (hDlg). Our results show that E6 variants differentially modulate hDlg degradation, rebounding in levels of activated PTEN and PKB. HPV18 E6 variants are also able to upregulate phospho-PI3K protein, strongly correlating with activated MAPKs and cell proliferation. Data was supported by the effect of E6 silencing in HPV18-containing HeLa cells, as well as hDlg silencing in the tested cells. Results suggest that HPV18 intra-type variations may derive in differential abilities to activate cell-signaling pathways such as Akt/PKB and MAPKs, directly involved in cell survival and proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19007961     DOI: 10.1016/j.virol.2008.09.040

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  30 in total

1.  Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells.

Authors:  Lizhi He; Alistair Ingram; Adrian P Rybak; Damu Tang
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  Akt Pathway Activation by Human T-cell Leukemia Virus Type 1 Tax Oncoprotein.

Authors:  Mathew A Cherian; Hicham H Baydoun; Jacob Al-Saleem; Nikoloz Shkriabai; Mamuka Kvaratskhelia; Patrick Green; Lee Ratner
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

3.  The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomas.

Authors:  Ryan T Anderson; Stephen B Keysar; Daniel W Bowles; Magdalena J Glogowska; David P Astling; J Jason Morton; Phuong Le; Adrian Umpierrez; Justin Eagles-Soukup; Gregory N Gan; Brian W Vogler; Daniel Sehrt; Sarah M Takimoto; Dara L Aisner; Francois Wilhelm; Barbara A Frederick; Marileila Varella-Garcia; Aik-Choon Tan; Antonio Jimeno
Journal:  Mol Cancer Ther       Date:  2013-07-19       Impact factor: 6.261

4.  A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins.

Authors:  Stephen B Keysar; David P Astling; Ryan T Anderson; Brian W Vogler; Daniel W Bowles; J Jason Morton; Jeramiah J Paylor; Magdalena J Glogowska; Phuong N Le; Justin R Eagles-Soukup; Severine L Kako; Sarah M Takimoto; Daniel B Sehrt; Adrian Umpierrez; Morgan A Pittman; Sarah M Macfadden; Ryan M Helber; Scott Peterson; Diana F Hausman; Sherif Said; Ted H Leem; Julie A Goddard; John J Arcaroli; Wells A Messersmith; William A Robinson; Fred R Hirsch; Marileila Varella-Garcia; David Raben; Xiao-Jing Wang; John I Song; Aik-Choon Tan; Antonio Jimeno
Journal:  Mol Oncol       Date:  2013-04-04       Impact factor: 6.603

Review 5.  The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.

Authors:  James A Scarth; Molly R Patterson; Ethan L Morgan; Andrew Macdonald
Journal:  J Gen Virol       Date:  2021-01-11       Impact factor: 3.891

6.  E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer.

Authors:  Ethan L Morgan; James A Scarth; Molly R Patterson; Christopher W Wasson; Georgia C Hemingway; Diego Barba-Moreno; Andrew Macdonald
Journal:  Cell Death Differ       Date:  2020-12-10       Impact factor: 15.828

Review 7.  The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.

Authors:  Lifang Zhang; Jianhong Wu; Ming Tat Ling; Liang Zhao; Kong-Nan Zhao
Journal:  Mol Cancer       Date:  2015-04-17       Impact factor: 27.401

8.  E6/E7 Functional Differences among Two Natural Human Papillomavirus 18 Variants in Human Keratinocytes.

Authors:  Emily Montosa Nunes; Valéria Talpe-Nunes; João Simão Sobrinho; Silvaneide Ferreira; Vanesca de Souza Lino; Lara Termini; Gabriela Ávila Fernandes Silva; Enrique Boccardo; Luisa Lina Villa; Laura Sichero
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

9.  The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species.

Authors:  Jennifer M Spangle; Karl Munger
Journal:  PLoS Pathog       Date:  2013-03-14       Impact factor: 6.823

10.  Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein.

Authors:  Anita Szalmás; Eszter Gyöngyösi; Annamária Ferenczi; Brigitta László; Tamás Karosi; Péter Csomor; Lajos Gergely; György Veress; József Kónya
Journal:  Virol J       Date:  2013-03-07       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.